Literature DB >> 7389187

Antibodies to denatured bovine collagens in sera of patients with liver disease.

T Suou, C Hirayama.   

Abstract

Sera from 101 patients with liver disease were studied for the presence of antibodies to three types of denatured bovine collagens by passive haemagglutination assay. A high incidence and titres were found especially in chronic active hepatitis, liver cirrhosis and primary hepatoma. The incidence and titres of antibodies to Type I and Type III collagens were significantly higher than those of antibodies to Type II collagen. Analysis by gel filtration on Sephadex G-200 or absorption with anti-IgG and IgM antisera revealed that the antibodies belonged to both IgG and IgM classes. They correlated with serum gamma-globulin levels, but not with rheumatoid factor.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7389187      PMCID: PMC1537937     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin.

Authors:  E J Miller
Journal:  Biochemistry       Date:  1972-12-19       Impact factor: 3.162

2.  [Demonstration of antibodies with different collagen specificity in progressive chronic polyarthritis and comparison of human collagen and calf collagen as test antigen].

Authors:  C Steffen; H Ludwig; N Thumb; O Frank; R Eberl; F Tausch
Journal:  Klin Wochenschr       Date:  1973-03-01

3.  The incidence and antigenic specificity of antibodies against denatured human collagen in rheumatoid arthritis.

Authors:  D Michaeli; H H Fudenberg
Journal:  Clin Immunol Immunopathol       Date:  1974-01

4.  Immunochemical properties of procollagen from dermatosparactic calves.

Authors:  R Timpl; G Wick; H Furthmayr; C M Lapiére; K Kühn
Journal:  Eur J Biochem       Date:  1973-02-01

5.  Consideration of pathogenesis of rheumatoid arthritis as collagen autoimmunity.

Authors:  C Steffen
Journal:  Z Immunitatsforsch Allerg Klin Immunol       Date:  1970-04

6.  A two-component system of human serum agglutinating gelating-coated erythrocytes.

Authors:  I Wolff; R Timpl; I Pecker; C Steffen
Journal:  Vital Health Stat 2       Date:  1967-06

7.  ["Collagen-like protein" (CLP) and collagen antibodies in the serum of chronic polyarthritis and non-rheumatic diseases of connective tissue].

Authors:  W Kriegel; U Langness; P Jahn
Journal:  Klin Wochenschr       Date:  1970-03-15

Review 8.  The immunology of liver disease.

Authors:  S Sherlock
Journal:  Am J Med       Date:  1970-11       Impact factor: 4.965

9.  Antibodies to collagen in patients with emphysema.

Authors:  D Michaeli; H H Fudenberg
Journal:  Clin Immunol Immunopathol       Date:  1974-11

10.  Serum collagen-like protein in patients with chronic liver disease.

Authors:  C Hirayama; M Kawabe; I Morotomi; N Kimura
Journal:  Digestion       Date:  1972       Impact factor: 3.216

View more
  5 in total

1.  Cellular sensitivity to collagen in liver disease.

Authors:  H Sawada; T Suou; C Hirayama
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

2.  Anti-albumin antibodies in sera of patients with gastro-intestinal disease.

Authors:  N Tamura
Journal:  Gastroenterol Jpn       Date:  1982

3.  Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis.

Authors:  Brian B Borg; Anil Seetharam; Vijay Subramanian; Haseeb Ilias Basha; Mauricio Lisker-Melman; Kevin Korenblat; Christopher D Anderson; Surendra Shenoy; William C Chapman; Jeffrey S Crippin; Thalachallour Mohanakumar
Journal:  Liver Transpl       Date:  2011-07       Impact factor: 5.799

4.  Anti-albumin antibodies in sera of patients with liver disease.

Authors:  N Tamura; T Suou; C Hirayama
Journal:  Gastroenterol Jpn       Date:  1982-10

5.  The diagnostic significance of anti-type II collagen antibody assay in rheumatoid arthritis.

Authors:  K Fujii; M Tsuji; A Kitamura; K Murota
Journal:  Int Orthop       Date:  1992       Impact factor: 3.075

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.